Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 6/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.38 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | XDH | P47989 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19342431 | 0.94 | ALDH1A1 (0.42) | ALDH1A1RECQLAPPHRH3L3MBTL1 | |
| SCHEMBL6727999 | 0.92 | PRMT1 (0.43) | ALDH1A1RECQLAPPHRH3L3MBTL1 | |
| SCHEMBL6046899 | 0.92 | PRMT1 (0.43) | ALDH1A1RECQLAPPHRH3L3MBTL1 | |
| SCHEMBL977250 | 0.89 | ALDH1A1 (0.56) | ALDH1A1RECQLAPPHRH3NR1I2 | |
| SCHEMBL24962608 | 0.86 | PDE2A (0.42) | ALDH1A1RECQLAPPXDH | |
| SCHEMBL30754665 | 0.86 | PDE2A (0.42) | ALDH1A1RECQLAPPXDH | |
| SCHEMBL38655982 | 0.85 | KCNA3 (0.48) | HRH3L3MBTL1PRSS1TMPRSS2KCNA3 | |
| SCHEMBL20969950 | 0.84 | PRSS1 (0.41) | ALDH1A1APPPRSS1KCNA3 | |
| SCHEMBL555384 | 0.84 | ALDH1A1 (0.56) | ALDH1A1RECQLHRH3NR1I2L3MBTL1 | |
| SCHEMBL4070878 | 0.81 | KCNA3 (0.39) | HRH3L3MBTL1PRSS1TMPRSS2KCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534670-B2 | Liquid crystal compounds | Rolic Technologies AG (CH) | 2026-01-27 | — | — | US | disclosed |
| US-20250066666-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2025-02-27 | — | — | US | disclosed |
| EP-4444822-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2024-10-16 | — | — | EP | disclosed |
| CN-118324638-A | Polymerizable liquid crystal compound, liquid crystal optical film based on polymerizable liquid crystal compound and preparation method of polymerizable liquid crystal compound | 长安大学 | 2024-07-12 | — | — | CN | disclosed |
| CN-118318024-A | Liquid crystal compound | 罗利克技术有限公司 | 2024-07-09 | — | — | CN | disclosed |
| WO-2023104545-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2023-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534670-B2 | Liquid crystal compounds | SCO2, LBR, C1R | ALDH1A1 2599/4885RECQL 2020/4885APP 1310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.